These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24324152)

  • 1. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination.
    Vono M; Taccone M; Caccin P; Gallotta M; Donvito G; Falzoni S; Palmieri E; Pallaoro M; Rappuoli R; Di Virgilio F; De Gregorio E; Montecucco C; Seubert A
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21095-100. PubMed ID: 24324152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
    Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
    J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
    Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
    Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically applicable adjuvant for an atherosclerosis vaccine in mice.
    Kobiyama K; Vassallo M; Mitzi J; Winkels H; Pei H; Kimura T; Miller J; Wolf D; Ley K
    Eur J Immunol; 2018 Sep; 48(9):1580-1587. PubMed ID: 29932463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
    Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen.
    Jiao XD; Cheng S; Hu YH; Sun L
    Vaccine; 2010 Feb; 28(7):1832-7. PubMed ID: 20006568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.
    Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A
    J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.
    Calabro S; Tortoli M; Baudner BC; Pacitto A; Cortese M; O'Hagan DT; De Gregorio E; Seubert A; Wack A
    Vaccine; 2011 Feb; 29(9):1812-23. PubMed ID: 21215831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
    Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
    J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology and efficacy of MF59-adjuvanted vaccines.
    Ko EJ; Kang SM
    Hum Vaccin Immunother; 2018; 14(12):3041-3045. PubMed ID: 30015572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.
    Higgins DA; Carlson JR; Van Nest G
    Vaccine; 1996 Apr; 14(6):478-84. PubMed ID: 8782343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli G; Groth N; Del Giudice G
    Hum Vaccin Immunother; 2012 Feb; 8(2):216-27. PubMed ID: 22426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life.
    Mastelic Gavillet B; Eberhardt CS; Auderset F; Castellino F; Seubert A; Tregoning JS; Lambert PH; de Gregorio E; Del Giudice G; Siegrist CA
    J Immunol; 2015 May; 194(10):4836-45. PubMed ID: 25870238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
    Galli G; Hancock K; Hoschler K; DeVos J; Praus M; Bardelli M; Malzone C; Castellino F; Gentile C; McNally T; Del Giudice G; Banzhoff A; Brauer V; Montomoli E; Zambon M; Katz J; Nicholson K; Stephenson I
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7962-7. PubMed ID: 19416838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
    Valensi JP; Carlson JR; Van Nest GA
    J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
    Banzhoff A; Pellegrini M; Del Giudice G; Fragapane E; Groth N; Podda A
    Influenza Other Respir Viruses; 2008 Nov; 2(6):243-9. PubMed ID: 19453401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    Cioncada R; Maddaluno M; Vo HTM; Woodruff M; Tavarini S; Sammicheli C; Tortoli M; Pezzicoli A; De Gregorio E; Carroll MC; D'Oro U; Piccioli D
    PLoS One; 2017; 12(10):e0185843. PubMed ID: 29088224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.